Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 1.996% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCOC(=O)c1ccc(NC(=O)c2nn(C)cc2Br)cc1
b.) CCC1CCCCN1C(=O)Cn1c(=O)n(CCCC(=O)NCc2ccco2)c(=O)c2sccc21
c.) COc1ccc(Cn2c(CCC(=O)Nc3ccccc3OC)nc3cccnc32)cc1
d.) CC1CCN(C(=O)CSc2nnc(Cc3cccn3C)n2-c2ccc(F)cc2)CC1
e.) O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1ccccc1F
Answer: b. CCC1CCCCN1C(=O)Cn1c(=O)n(CCCC(=O)NCc2ccco2)c(=O)c2sccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1CCCCN1C(=O)Cn1c(=O)n(CCCC(=O)NCc2ccco2)c(=O)c2sccc21
CCC1CCCCN1C(=O)Cn1c(=O)n(CCCC(=O)NCc2ccco2)c(=O)c2sccc21
4-[1-[2-(2-ethylpiperidin-1-yl)-2-oxoethyl]-2,4-dioxothieno[3,2-d]pyrimidin-3-yl]-N-(furan-2-ylmethyl)butanamide